Citalopram hydrobromide and Vimpat drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Citalopram hydrobromide (citalopram hydrobromide) and Vimpat (lacosamide). Common drug interactions include completed suicide among females and convulsion among males.

The phase IV clinical study analyzes what interactions people have when they take Citalopram hydrobromide and Vimpat. It is created by eHealthMe based on reports of 56 people who take the same drugs from the FDA, and is updated regularly.

What is Citalopram hydrobromide?

Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,880 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.

What is Vimpat?

Vimpat has active ingredients of lacosamide. It is often used in epilepsy. eHealthMe is studying from 20,832 Vimpat users. Check the latest studies of Vimpat.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 01, 2026

56 people who take Citalopram hydrobromide and Vimpat together, and have interactions are studied.

Citalopram hydrobromide and Vimpat drug interactions.

What are the common drug interactions of Citalopram Hydrobromide and Vimpat, by gender? *:

female:

  1. Completed suicide (act of taking one's own life)
  2. Overdose
  3. Cellulitis (infection under the skin)
  4. Pruritus (severe itching of the skin)
  5. Wrist fracture
  6. Fall
  7. Suicidal ideation
  8. Poisoning
  9. Insomnia (sleeplessness)
  10. Pollakiuria (abnormally frequent passage of relatively small quantities or urine)

male:

  1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  2. Confusional state
  3. Influenza like illness
  4. Central nervous system necrosis (destruction of central nervous system)
  5. Drug level decreased
  6. Pyrexia (fever)
  7. Accidental exposure
  8. Back pain
  9. Blood sodium decreased
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Citalopram Hydrobromide and Vimpat, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Blood cholesterol increased
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Oral herpes (viral infection of mouth)
  4. Syphilis (sexually transmitted , chronic bacterial disease caused by the spirochete treponema pallidum)

20-29:

  1. Fall
  2. Psoriasis (immune-mediated disease that affects the skin)
  3. Weight increased

30-39:

  1. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  2. Accidental exposure
  3. Ankle fracture
  4. Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
  5. Dermatitis allergic (inflammation of the skin due allergic reaction)
  6. Drug intolerance (drug sensitivity)
  7. Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions)
  8. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  9. Rash
  10. Syncope (loss of consciousness with an inability to maintain postural tone)

40-49:

  1. Completed suicide (act of taking one's own life)
  2. Overdose
  3. Cellulitis (infection under the skin)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Pruritus (severe itching of the skin)
  6. Wrist fracture
  7. Suicidal ideation
  8. Poisoning
  9. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  10. Central nervous system abscess (collection of pus in brain)

50-59:

  1. Abnormal behaviour
  2. Confusional state
  3. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  4. Fall
  5. Laceration (tearing of soft body tissue)
  6. Drug level decreased
  7. Somnolence (a state of near-sleep, a strong desire for sleep)
  8. Sudden unexplained death in epilepsy

60+:

  1. Chest pain
  2. Dizziness
  3. Hot flush (sudden feelings of heat)
  4. Laceration (tearing of soft body tissue)
  5. Oestradiol decreased
  6. Pain in extremity
  7. Skin fissures (a crack in the skin)
  8. Skin haemorrhage (bleeding into skin)
  9. Dermatitis atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder)
  10. Injection site pruritus (severe itching at injection site)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 11 people, 19.64%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 6 people, 10.71%
  3. Pain: 6 people, 10.71%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 8.93%
  5. Nocardia Infection (a bacterial infection that usually starts in the lungs. it may spread to other organ systems): 4 people, 7.14%
  6. Eosinophilic Pustular Folliculitis (bacterial skin diseases): 4 people, 7.14%
  7. Dyslipidaemia (abnormal amount of lipids): 4 people, 7.14%
  8. Abscess (pus): 4 people, 7.14%
  9. Stress And Anxiety: 3 people, 5.36%
  10. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 5.36%

* Approximation only. Some reports may have incomplete information.

Do you take Citalopram hydrobromide and Vimpat?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Citalopram hydrobromide and Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Citalopram hydrobromide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vimpat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Citalopram hydrobromide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vimpat and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on citalopram hydrobromide and lacosamide (the active ingredients of Citalopram hydrobromide and Vimpat, respectively), and Citalopram hydrobromide and Vimpat (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: